The following article brings up a topic that has been of great concern to me for some time. My mother used to tell me to read something that wasn’t so serious. Those words ring in my ear from time to time when I am reading articles like these. Starting at the turn of the year, veterinarians will be needed to write feed directives and prescriptions for livestock producers to help preserve our antibiotics needed for human health……..
WASHINGTON — Carbapenems are one of the most important classes of antibiotics used in humans, and are an important agent against multi-drug resistant bacteria. Now, for the first time, bacteria that carry a transmissible carbapenem resistance gene have been found in agricultural animals in the United States. The research is published in December 5th in Antimicrobial Agents and Chemotherapy, a journal of the American Society for Microbiology.
Carbapenem resistant bacteria are not uncommon in hospitals. However, in the US, carbapenems are not used in agriculture because of their importance to human health. “It’s a surprise that they would show up in livestock,” said corresponding author, Thomas Wittum, PhD, Professor and Chair of Veterinary Preventive Medicine, The Ohio State University.
Like many antibiotic resistance genes, the carbapenem resistance gene in this report, called bla IMP-27, is carried by a plasmid. Plasmids are small pieces of independent DNA that can move easily from one bacterium to another, including across species.
Additionally, the particular plasmid on which bla IMP-27 was found has one of the widest host ranges of any plasmid, said first author Dixie Mollenkopf, a graduate student in Wittum’s lab.
This combination of attributes, and the fact that carbapenem resistance was recently designated an urgent threat to public health by the Centers for Disease Control and Prevention led the researchers to investigate whether bacteria with carbapenem resistance genes such as bla-imp-27 might be present in agricultural animals or in agricultural settings, said Wittum.
The investigators used gauze swabs to obtain samples from floors and walls of pens, as well as swiffers, to collect environmental and fecal samples from a 1,500 sow, farrow-to-finish pig farm during four visits over five months. Despite all the work they had put into the study, they were still surprised to find carbapenem-resistant bacteria growing in the agar plates, said Mollenkopf. Nonetheless, the numbers of isolates bearing bla IMP-27 were few.
Furthermore, the resistance gene was present primarily in environmental samples from the farrowing operation, and the investigators failed to find it in pigs being fattened for slaughter. “There is no evidence the pigs carried the gene into the [human] food supply,” said Wittum.
Still, finding the gene at all on this particular farm was somewhat mysterious because no new livestock were introduced on it during the past 50 years, said Wittum. The farm had bred all of its animals during this time.
Carbapenems are a subset of β-lactam antibiotics. Β-lactam antibiotics which are not carbapenems are legal for use on farms in the US. This study’s results support the investigators’ hypothesis that the use of Ceftiofur, a β-lactam antibiotic, might be selecting for resistance to carbapenems on farms.
The investigators suggest that in light of their results, monitoring farms will be important, to ensure that they do not become a source of bacteria with carbapenem resistance genes such as of bla IMP-27 within the human population. Additionally, “We may need to examine some of the practices of farms, and evaluate whether they are really appropriate, and whether the benefits outweigh the risks,” said Wittum. Such practices include administering Ceftiofur, to all piglets in the farrowing barns rather than just those that happen to sicken, an FDA-approved application known as “disease control.”
–American Society for Microbiology
– See more at: https://www.morningagclips.com/resistance-to-drug-of-last-resort-found/?utm_content=articles&utm_campaign=NLCampaign&utm_source=Newsletter&utm_term=newsletteredition&utm_medium=email#sthash.qycZkehL.dpuf